0.82 USD
▼-0.06-7.10%
盘后 1.13 0.00%
2026-09-16
市值
$14.18M
市盈率
0.00
EPS
382.20
股息率
—
52 周区间
0.80 – 27.15
成交量
380.78K
Beta
1.42
目标价
—
52W 低 0.8052W 高 27.15
价格走势
公司简介
Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was forme...